NPCE EBITDA Margin
Neuropace Inc · EBITDA Margin
NPCE EBITDA Margin
Latest reported-11.56%period ending
NPCE TTM EBITDA Margin (-30.28% → -11.56%)
TTM ebitda margin
High-resolution chart · PNG
NPCE ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -11.5585% | |
| -13.4713% | |
| -12.7288% | |
| -15.5243% | |
| -17.5172% | |
| -16.9668% | |
| -20.7419% | |
| -22.919% | |
| -26.972% | |
| -30.4938% | |
| -34.9032% | |
| -46.068% | |
| -58.6295% | |
| -73.4337% | |
| -80.3295% | |
| -84.3053% | |
| -79.0189% | |
| -66.974% | |
| -62.798% | |
| -49.5928% | |
| -36.6012% | |
| -37.0057% | |
| -30.281% |